Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87


What do we really know about how CD4 T cells control Mycobacterium tuberculosis?

Torrado E, Cooper AM.

PLoS Pathog. 2011 Jul;7(7):e1002196. doi: 10.1371/journal.ppat.1002196. No abstract available.


Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse.

Winslow GM, Roberts AD, Blackman MA, Woodland DL.

J Immunol. 2003 Feb 15;170(4):2046-52.


Antigen smuggling in tuberculosis.

Hudrisier D, Neyrolles O.

Cell Host Microbe. 2014 Jun 11;15(6):657-9. doi: 10.1016/j.chom.2014.05.018.


Protective immunity afforded by attenuated, PhoP-deficient Mycobacterium tuberculosis is associated with sustained generation of CD4+ T-cell memory.

Nambiar JK, Pinto R, Aguilo JI, Takatsu K, Martin C, Britton WJ, Triccas JA.

Eur J Immunol. 2012 Feb;42(2):385-92. doi: 10.1002/eji.201141903.


Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection.

Caccamo N, Guggino G, Joosten SA, Gelsomino G, Di Carlo P, Titone L, Galati D, Bocchino M, Matarese A, Salerno A, Sanduzzi A, Franken WP, Ottenhoff TH, Dieli F.

Eur J Immunol. 2010 Aug;40(8):2211-20. doi: 10.1002/eji.201040455.


Interaction between HIV and Mycobacterium tuberculosis: HIV-1-induced CD4 T-cell depletion and the development of active tuberculosis.

Geldmacher C, Zumla A, Hoelscher M.

Curr Opin HIV AIDS. 2012 May;7(3):268-75. doi: 10.1097/COH.0b013e3283524e32. Review.


Killer cell lectin-like receptor G1 deficiency significantly enhances survival after Mycobacterium tuberculosis infection.

Cyktor JC, Carruthers B, Stromberg P, Flaño E, Pircher H, Turner J.

Infect Immun. 2013 Apr;81(4):1090-9. doi: 10.1128/IAI.01199-12.


Mycobacterial lipopeptides elicit CD4+ CTLs in Mycobacterium tuberculosis-infected humans.

Bastian M, Braun T, Bruns H, Röllinghoff M, Stenger S.

J Immunol. 2008 Mar 1;180(5):3436-46.


Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation.

Woodworth JS, Aagaard CS, Hansen PR, Cassidy JP, Agger EM, Andersen P.

J Immunol. 2014 Apr 1;192(7):3247-58. doi: 10.4049/jimmunol.1300283.


IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection.

Green AM, Difazio R, Flynn JL.

J Immunol. 2013 Jan 1;190(1):270-7. doi: 10.4049/jimmunol.1200061.


The immunopathogenesis of tuberculosis: a new working hypothesis.

Orme IM.

Trends Microbiol. 1998 Mar;6(3):94-7. No abstract available.


Dissecting memory T cell responses to TB: concerns using adoptive transfer into immunodeficient mice.

Ancelet L, Rich FJ, Delahunt B, Kirman JR.

Tuberculosis (Edinb). 2012 Sep;92(5):422-33. doi: 10.1016/


DR*W201/P65 tetramer visualization of epitope-specific CD4 T-cell during M. tuberculosis infection and its resting memory pool after BCG vaccination.

Wei H, Wang R, Yuan Z, Chen CY, Huang D, Halliday L, Zhong W, Zeng G, Shen Y, Shen L, Wang Y, Chen ZW.

PLoS One. 2009 Sep 4;4(9):e6905. doi: 10.1371/journal.pone.0006905.


Direct ex vivo detection of HLA-DR3-restricted cytomegalovirus- and Mycobacterium tuberculosis-specific CD4+ T cells.

Bronke C, Palmer NM, Westerlaken GH, Toebes M, van Schijndel GM, Purwaha V, van Meijgaarden KE, Schumacher TN, van Baarle D, Tesselaar K, Geluk A.

Hum Immunol. 2005 Sep;66(9):950-61.


Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection.

Cruz A, Khader SA, Torrado E, Fraga A, Pearl JE, Pedrosa J, Cooper AM, Castro AG.

J Immunol. 2006 Aug 1;177(3):1416-20.


Double- and monofunctional CD4⁺ and CD8⁺ T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals.

Commandeur S, Lin MY, van Meijgaarden KE, Friggen AH, Franken KL, Drijfhout JW, Korsvold GE, Oftung F, Geluk A, Ottenhoff TH.

Eur J Immunol. 2011 Oct;41(10):2925-36. doi: 10.1002/eji.201141602.


Lymphocyte subpopulations in pulmonary tuberculosis patients.

Deveci F, Akbulut HH, Celik I, Muz MH, Ilhan F.

Mediators Inflamm. 2006;2006(2):89070.

Supplemental Content

Support Center